Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
Company Contact | |
Address: | 512 E. Madison Ave. Suite A1 BELGRADE MT 59714 |
Tel: | N/A |
Website: | N/A |
IR: | N/A |
Key People | ||
Guy S. Cook Chief Executive Officer, Director | Donna Medina Interim Chief Financial Officer |
Business Overview |
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company's products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company's stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges. |
Financial Overview |
For the nine months ended 30 June 2021, Lattice Biologics Ltd revenues decreased 54% to $762K. Net loss decreased 43% to $712K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Salaries decrease of 42% to $339K (expense), Interest and Finance Charges decrease of 59% to $143K (expense), General and Administrative decrease of 39% to $84K (expense). |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $8.43M as of Jun 30, 2021 |
Annual revenue (TTM): | $2.14M as of Jun 30, 2021 |
EBITDA (TTM): | -$0.37M as of Jun 30, 2021 |
Net annual income (TTM): | -$1.31M as of Jun 30, 2021 |
Free cash flow (TTM): | -$0.96M as of Jun 30, 2021 |
Net Debt Last Fiscal Year: | $0.00M as of Jun 30, 2021 |
Shares outstanding: | 128,218,300 as of Jun 30, 2021 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |